Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Drug Resistance

  Free Subscription


06.01.2025

1 Antimicrob Agents Chemother
2 Int J Antimicrob Agents
11 J Antimicrob Chemother
1 J Infect Dis
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. JEHANNE Q, Benejat L, Ducournau A, Aptel J, et al
    Increasing rates of erm(B) and erm(N) in human Campylobacter coli and Campylobacter jejuni erythromycin-resistant isolates between 2018 and 2023 in France.
    Antimicrob Agents Chemother. 2024 Dec 31:e0166824. doi: 10.1128/aac.01668.
    PubMed         Abstract available


    Int J Antimicrob Agents

  2. ZHANG J, Du L, Shi Q, Li X, et al
    Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: a prospective multicenter cohort study.
    Int J Antimicrob Agents. 2024 Dec 30:107427.
    PubMed         Abstract available

  3. WAN X, Miao R, Zhang N, Huang W, et al
    Global burden of antimicrobial resistance in lower respiratory infections in 2021: a systematic analysis.
    Int J Antimicrob Agents. 2024 Dec 27:107431.
    PubMed         Abstract available


    J Antimicrob Chemother

  4. KIM SH, Kim HM, Chung DR, Ko JH, et al
    Synergistic effects of colistin-rifampin-based triple antimicrobial combination therapy against Carbapenem-resistant Pseudomonas aeruginosa: a time-kill assay.
    J Antimicrob Chemother. 2024 Dec 31:dkae466. doi: 10.1093.
    PubMed         Abstract available

  5. MARCELIN AG, Soulie C, Wirden M, Barriere G, et al
    Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study.
    J Antimicrob Chemother. 2025;80:95-101.
    PubMed         Abstract available

  6. PARIONA JGM, Vasquez-Ponce F, Pariona EMM, Sousa-Carmo RR, et al
    Efficacy of meropenem against ceftazidime-avibactam-resistant Klebsiella pneumoniae producing KPC-31, KPC-33, KPC-90, KPC-106 and KPC-114.
    J Antimicrob Chemother. 2025;80:162-168.
    PubMed         Abstract available

  7. ROBERTSON A, Coutinho G, Mantzourani E, Szomolay B, et al
    Over-the-counter antibiotics compromising aminoglycoside activity.
    J Antimicrob Chemother. 2025;80:87-94.
    PubMed         Abstract available

  8. ANDO N, Mizushima D, Takano M, Mitobe M, et al
    Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium.
    J Antimicrob Chemother. 2025;80:247-253.
    PubMed         Abstract available

  9. HIRABAYASHI A, Yano H, Yahara K, Aoki S, et al
    Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan.
    J Antimicrob Chemother. 2025;80:192-199.
    PubMed         Abstract available

  10. BALTAS I, Patel T, Soares AL
    Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?
    J Antimicrob Chemother. 2025;80:59-67.
    PubMed         Abstract available

  11. CHEN S, Shang Y, Zheng J, Huo F, et al
    In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis.
    J Antimicrob Chemother. 2025;80:262-269.
    PubMed         Abstract available

  12. YANXIA S, Xuewei W, Gang L, Wei J, et al
    Analysis on characteristics and multilocus sequence typing of Clostridium perfringens in western China.
    J Antimicrob Chemother. 2025;80:216-226.
    PubMed         Abstract available

  13. MELLO TP, Ramos LS, Andrade VV, Torres-Santos EC, et al
    Elucidating the augmented resistance profile of Scedosporium/Lomentospora species to azoles in a cystic fibrosis mimic environment.
    J Antimicrob Chemother. 2025;80:106-115.
    PubMed         Abstract available

  14. MOREY F, Giron-Callejas A, Manzanero R, Urbina A, et al
    Pretreatment and acquired HIV drug resistance in Belize-results of nationally representative surveys, 2021-22.
    J Antimicrob Chemother. 2025;80:292-300.
    PubMed         Abstract available


    J Infect Dis

  15. LI Y, Mishra NN, Chen L, Manna AC, et al
    Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024 Dec 31:jiae640. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  16. HRALA M, Andrla P, Bosak J, Fedrova P, et al
    Whole genome sequences of nine Taylorella equigenitalis strains isolated in the Czech Republic between 1982-2021: Molecular dating suggests a common ancestor at the time of Roman Empire.
    PLoS One. 2025;20:e0315946.
    PubMed         Abstract available

  17. ZHOU Q, Pu N, Xu G, Liu H, et al
    Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis.
    PLoS One. 2025;20:e0315512.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.